Global CNS Epidemiology Market - Strategic Insights and Forecasts (2026-2031)

Growth is driven by aging populations, rising neurodegenerative disease burden, increasing mental health disorders, and expanding adoption of real-world evidence and digital health registries.

Aging populations significantly increase the prevalence of Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions, leading to higher demand for longitudinal epidemiological studies.

Key challenges include underdiagnosis, inconsistent data standardization, limited neurological infrastructure in developing regions, and long disease progression timelines.

AI and machine learning are used for predictive modeling, disease burden forecasting, pattern recognition, and integration of large-scale neurological datasets.

North America leads due to advanced healthcare infrastructure, followed by Europe with strong public health systems, and Asia Pacific showing rapid growth due to aging populations and healthcare digitization.